Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia

A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia

(2011) Bruce J. Kinon et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia

(2010) Shigeyuki Chaki   EUROPEAN JOURNAL OF PHARMACOLOGY

Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems

(2010) Joanna M. Wierońska et al.   NEUROPHARMACOLOGY

On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039

(2010) Agnieszka Pałucha-Poniewiera et al.   PSYCHOPHARMACOLOGY

Selective activation of metabotropic G-protein-coupled glutamate 7 receptor elicits anxiolytic-like effects in mice by modulating GABAergic neurotransmission

(2009) Katarzyna Stachowicz et al.   BEHAVIOURAL PHARMACOLOGY

Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism

(2009) Corinne Beurrier et al.   FASEB JOURNAL

Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs

(2009) Joanna M. Wierońska et al.   NEUROCHEMISTRY INTERNATIONAL

The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems

(2009) K. Stachowicz et al.   NEUROPHARMACOLOGY

Evidence for the Role of Metabotropic Glutamate (mGlu)2 Not mGlu3 Receptors in the Preclinical Antipsychotic Pharmacology of the mGlu2/3 Receptor Agonist (-)-(1R,4S,5S,6S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic Acid (LY404039)

(2008) M. J. Fell et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents

(2008) A. Pałucha-Poniewiera et al.   NEUROPHARMACOLOGY

Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia

(2008) P. Jeffrey Conn et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

The metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats

(2007) Xia Li et al.   NEUROPHARMACOLOGY

Group III mGluR regulation of synaptic transmission at the SC-CA1 synapse is developmentally regulated

(2007) Jennifer E. Ayala et al.   NEUROPHARMACOLOGY